Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Completed · Phase 2 · Has a placebo group

Conditions studied: Amyotrophic Lateral Sclerosis

In brief

This study evaluates NP001 in patients with amyotrophic lateral sclerosis (ALS) and evidence of systemic inflammation. Half of participants will receive NP001 and the other half will receive placebo.

Key facts

Study ID

NCT02794857

Run by

Neuraltus Pharmaceuticals, Inc.

People needed

138

Starts

2016-08-29

Expected to finish

2017-12-12

Last updated by the study team

2018-05-07

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics — Phoenix, Arizona, United States
• Mayo Clinic Arizona — Scottsdale, Arizona, United States
• Cedars-Sinai Medical Center — Los Angeles, California, United States
• University of California, Irvine, Department of Neurology — Orange, California, United States
• Forbes Norris MDA/ALS Research Center, CPMC — San Francisco, California, United States
• Mayo Clinic Florida — Jacksonville, Florida, United States
• University of Miami Miller School of Medicine — Miami, Florida, United States
• Emory University, Department of Neurology — Atlanta, Georgia, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• University of Kentucky, Albert B. Chandler Medical Center — Lexington, Kentucky, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Clinical & Translational Science Institute, University of Minnesota — Minneapolis, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Columbia University Medical Center — New York, New York, United States
• Carolinas Medical Center, Neurosciences Instutite-Neurology — Charlotte, North Carolina, United States
• Duke Neurological Disorders Clinic at Morreene Road — Durham, North Carolina, United States
• Cleveland Clinic Foundation-Cleveland Clinic Hospital — Cleveland, Ohio, United States
• The Ohio State University Wexner Medical Center — Columbus, Ohio, United States
• Providence Brain & Spine Institute, ALS Center — Portland, Oregon, United States
• Houston Methodist Neurological Institute — Houston, Texas, United States
• University of Texas Health Sciences Center San Antonio — San Antonio, Texas, United States
• Montreal Neurological Institute — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.